Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: discovery of a weak cocaine "antagonist"

1993 ◽  
Vol 36 (24) ◽  
pp. 3975-3977 ◽  
Author(s):  
Daniele Simoni ◽  
Johannes Stoelwinder ◽  
Alan P. Kozikowski ◽  
Kenneth M. Johnson ◽  
John S. Bergmann ◽  
...  
MedChemComm ◽  
2017 ◽  
Vol 8 (12) ◽  
pp. 2216-2227 ◽  
Author(s):  
Wiktoria Jedwabny ◽  
Szymon Kłossowski ◽  
Trupta Purohit ◽  
Tomasz Cierpicki ◽  
Jolanta Grembecka ◽  
...  

A computationally affordable, non-empirical model based on electrostatic multipole and dispersion terms successfully predicts the binding affinity of inhibitors of menin–MLL protein–protein interactions.


2019 ◽  
Vol 29 (19) ◽  
pp. 126607 ◽  
Author(s):  
Hirofumi Tsujino ◽  
Tadayuki Uno ◽  
Taku Yamashita ◽  
Masafumi Katsuda ◽  
Kazuki Takada ◽  
...  

1994 ◽  
Vol 4 (2) ◽  
pp. 303-308 ◽  
Author(s):  
Johannes Stoelwinder ◽  
Marinella Roberti ◽  
Alan P. Kozikowski ◽  
Kenneth M. Johnson ◽  
John S. Bergmann

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Vishwambhar Vishnu Bhandare ◽  
Bajarang Vasant Kumbhar ◽  
Ambarish Kunwar

1988 ◽  
Vol 529 (1 Fourth Colloq) ◽  
pp. 239-241
Author(s):  
SAUDHAMINI PARTHASARATHY ◽  
ANDREA CHIN ◽  
VIRGINIA MALLOY ◽  
JONATHAN MATIAS

2018 ◽  
Vol 29 (1) ◽  
pp. 271-279 ◽  
Author(s):  
E. Ghorani ◽  
R. Rosenthal ◽  
N. McGranahan ◽  
J.L. Reading ◽  
M. Lynch ◽  
...  

Biomolecules ◽  
2020 ◽  
Vol 10 (3) ◽  
pp. 486 ◽  
Author(s):  
Amanat Ali ◽  
Seham Abdullah Rashed Alzeyoudi ◽  
Shamma Abdulla Almutawa ◽  
Alya Nasir Alnajjar ◽  
Yusra Al Dhaheri ◽  
...  

Angiotensin-I converting enzyme (ACE) is a zinc metallopeptidase that has an important role in regulating the renin-angiotensin-aldosterone system (RAAS). It is also an important drug target for the management of cardiovascular diseases. Hemorphins are endogenous peptides that are produced by proteolytic cleavage of beta hemoglobin. A number of studies have reported various therapeutic activities of hemorphins. Previous reports have shown antihypertensive action of hemorphins via the inhibition of ACE. The sequence of hemorphins is highly conserved among mammals, except in camels, which harbors a unique Q>R variation in the peptide. Here, we studied the ACE inhibitory activity of camel hemorphins (LVVYPWTRRF and YPWTRRF) and non-camel hemorphins (LVVYPWTQRF and YPWTQRF). Computational methods were used to determine the most likely binding pose and binding affinity of both camel and non-camel hemorphins within the active site of ACE. Molecular dynamics simulations showed that the peptides interacted with critical residues in the active site of ACE. Notably, camel hemorphins showed higher binding affinity and sustained interactions with all three subsites of the ACE active site. An in vitro ACE inhibition assay showed that the IC50 of camel hemorphins were significantly lower than the IC50 of non-camel hemorphins.


2009 ◽  
Vol 37 (7) ◽  
pp. 2126-2141 ◽  
Author(s):  
Akiko Takeuchi ◽  
David Schmitt ◽  
Charles Chapple ◽  
Elena Babaylova ◽  
Galina Karpova ◽  
...  

2021 ◽  
Vol 22 (22) ◽  
pp. 12272
Author(s):  
Rania Hamdy ◽  
Arwyn T. Jones ◽  
Mohamed El-Sadek ◽  
Alshaimaa M. Hamoda ◽  
Sarra B. Shakartalla ◽  
...  

A series of 3-(6-substituted phenyl-[1,2,4]-triazolo[3,4-b]-[1,3,4]-thiadiazol-3-yl)-1H-indoles (5a–l) were designed, synthesized and evaluated for anti-apoptotic Bcl-2-inhibitory activity. Synthesis of the target compounds was readily accomplished through a reaction of acyl hydrazide (1) with carbon disulfide in the presence of alcoholic potassium hydroxide to afford the corresponding intermediate potassium thiocarbamate salt (2), which underwent cyclization reaction in the presence of excess hydrazine hydrate to the corresponding triazole thiol (3). Further cyclisation reaction with substituted benzoyl chloride derivatives in the presence of phosphorous oxychloride afforded the final 6-phenyl-indol-3-yl [1,2,4]-triazolo[3,4-b]-[1,3,4]-thiadiazole compounds (5a–l). The novel series showed selective sub-micromolar IC50 growth-inhibitory activity against Bcl-2-expressing human cancer cell lines. The most potent 6-(2,4-dimethoxyphenyl) substituted analogue (5k) showed selective IC50 values of 0.31–0.7 µM against Bcl-2-expressing cell lines without inhibiting the Bcl-2-negative cell line (Jurkat). ELISA binding affinity assay (interruption of Bcl-2-Bim interaction) showed potent binding affinity for (5k) with an IC50 value of 0.32 µM. Moreover, it fulfils drug likeness criteria as a promising drug candidate.


2020 ◽  
Vol 179 ◽  
pp. 108266
Author(s):  
Yi-Shuan Peng ◽  
Huang-Tzu Wu ◽  
Yi-Chen Lai ◽  
Jian-Lin Chen ◽  
Ya-Chin Yang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document